BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 14668771)

  • 1. Tc-99m tetrofosmin tomography after nitrate administration in patients with ischemic left ventricular dysfunction: relation to metabolic imaging by PET.
    He W; Acampa W; Mainolfi C; Menna F; Sorrentino AR; Petretta M; Cuocolo A
    J Nucl Cardiol; 2003; 10(6):599-606. PubMed ID: 14668771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline/post-nitrate Tc-99m tetrofosmin mismatch for the assessment of myocardial viability in patients with severe left ventricular dysfunction: comparison with baseline Tc-99m tetrofosmin scintigraphy/FDG PET imaging.
    Giorgetti A; Marzullo P; Sambuceti G; Di Quirico S; Kusch A; Landi P; Salvadori PA; Pisani P; L'abbate A
    J Nucl Cardiol; 2004; 11(2):142-51. PubMed ID: 15052245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of nitrate augmented Tc-99m tetrofosmin gated SPECT imaging with FDG PET imaging for the assessment of myocardial viability in patients with severe left ventricular dysfunction.
    Raja S; Singh B; Rohit MK; Manohar K; Kashyap R; Bhattacharya A; Mittal BR
    J Nucl Cardiol; 2012 Dec; 19(6):1176-81. PubMed ID: 22872319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiac tomography with 99mTc-tetrofosmin after nitrate administration in patients with ischemic cardiopathy and left ventricular dysfunction].
    Menna F; Acampa W; Florimonte L; Ferro A; Borrelli G; Mainolfi C; Cuocolo A
    Radiol Med; 2000 Apr; 99(4):258-63. PubMed ID: 10884826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The quest for myocardial viability: Is there a role for nitrate-enhanced imaging?
    Di Carli MF
    J Nucl Cardiol; 2003; 10(6):696-9. PubMed ID: 14668784
    [No Abstract]   [Full Text] [Related]  

  • 6. Exercise-test Tc-99m tetrofosmin SPECT in patients with chronic ischemic left ventricular dysfunction: direct comparison with Ti-201 reinjection.
    Nicolai E; Cuocolo A; Acampa W; Varrone A; Pace L; Salvatore M
    J Nucl Cardiol; 1999; 6(3):270-7. PubMed ID: 10385182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline/postnitrate tetrofosmin SPECT for myocardial viability assessment in patients with postischemic severe left ventricular dysfunction: new evidence from MRI.
    Giorgetti A; Pingitore A; Favilli B; Kusch A; Lombardi M; Marzullo P
    J Nucl Med; 2005 Aug; 46(8):1285-93. PubMed ID: 16085584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dobutamine stress echocardiography and technetium-99m-tetrofosmin/fluorine 18-fluorodeoxyglucose single-photon emission computed tomography and influence of resting ejection fraction to assess myocardial viability in patients with severe left ventricular dysfunction and healed myocardial infarction.
    Rambaldi R; Poldermans D; Bax JJ; Boersma E; Valkema R; Elhendy A; Vletter WB; Fioretti PM; Roelandt JR; Krenning EP
    Am J Cardiol; 1999 Jul; 84(2):130-4. PubMed ID: 10426327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the prognostic value of SPECT after nitrate administration and metabolic imaging by PET in patients with ischaemic left ventricular dysfunction.
    Sorrentino AR; Acampa W; Petretta M; Mainolfi C; Salvatore M; Cuocolo A
    Eur J Nucl Med Mol Imaging; 2007 Apr; 34(4):558-62. PubMed ID: 17180660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitrate administration to enhance the detection of myocardial viability by technetium-99m tetrofosmin single-photon emission tomography.
    Flotats A; Carrió I; Estorch M; Bernà L; Catafau AM; Marí C; Ballester M
    Eur J Nucl Med; 1997 Jul; 24(7):767-73. PubMed ID: 9211763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technetium-99m-tetrofosmin imaging with incremental nitroglycerin infusion to detect severely ischaemic but viable myocardium: a comparative study with thallium-201.
    Kula M; Tutuş A; Unal S; Topsakal R; Ergin A
    Nucl Med Commun; 2003 Sep; 24(9):987-94. PubMed ID: 12960598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose dobutamine electrocardiograph-gated myocardial SPECT for identifying viable myocardium: comparison with dobutamine stress echocardiography and PET.
    Yoshinaga K; Morita K; Yamada S; Komuro K; Katoh C; Ito Y; Kuge Y; Kohya T; Kitabatake A; Tamaki N
    J Nucl Med; 2001 Jun; 42(6):838-44. PubMed ID: 11390545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of technetium 99m-tetrofosmin and thallium-201 single photon emission computed tomographic imaging for the assessment of viable myocardium in patients with left ventricular dysfunction.
    Galassi AR; Tamburino C; Grassi R; Foti R; Mammana C; Virgilio A; Licciardello G; Musumeci S; Giuffrida G
    J Nucl Cardiol; 1998; 5(1):56-63. PubMed ID: 9504874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sestamibi SPECT in the detection of myocardial viability in patients with chronic ischemic left ventricular dysfunction: comparison between visual and quantitative analysis.
    Acampa W; Petretta M; Florimonte L; di Santolo MS; Cuocolo A
    J Nucl Cardiol; 2000; 7(5):406-13. PubMed ID: 11083188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative assessment of 18F-fluorodeoxyglucose PET and 99mTc-tetrofosmin SPECT for the prediction of functional recovery in patients with reperfused acute myocardial infarction.
    Shirasaki H; Nakano A; Uzui H; Yonekura Y; Okazawa H; Ueda T; Lee JD
    Eur J Nucl Med Mol Imaging; 2006 Aug; 33(8):879-86. PubMed ID: 16586079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dobutamine stress electrocardiography-gated Tc-99m tetrofosmin SPECT for detection of viable but dysfunctional myocardium.
    Yamagishi H; Akioka K; Hirata K; Sakanoue Y; Toda I; Yoshiyama M; Teragaki M; Takeuchi K; Yoshikawa J; Ochi H
    J Nucl Cardiol; 2001; 8(1):58-67. PubMed ID: 11182710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of myocardial viability using perfusion cardiac SPECT. 201-thallium rest/redistribution, 201-thallium rest/reinjection and technetium 99m tetrofosmin rest/postnitrates].
    Flotats Giralt A; Carrió Gasset I; Estorch Cabrera M; Bernà Roqueta L; Catafau Alcántara AM; Marí Aparici C; Ballester Rodés M
    Rev Esp Cardiol; 1998; 51 Suppl 1():45-52. PubMed ID: 9549398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and image quality of dual-isotope SPECT using 18F-FDG and (99m)Tc-tetrofosmin after acipimox administration.
    Kam BL; Valkema R; Poldermans D; Bax JJ; Reijs AE; Rambaldi R; Boersma E; Rietveld T; Roelandt JR; Krenning EP
    J Nucl Med; 2003 Feb; 44(2):140-5. PubMed ID: 12571201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of microsphere-equivalent blood flow (15O-water PET) and relative perfusion (99mTc-tetrofosmin SPECT) in myocardium showing metabolism-perfusion mismatch.
    Schaefer WM; Nowak B; Kaiser HJ; Koch KC; Block S; vom Dahl J; Buell U
    J Nucl Med; 2003 Jan; 44(1):33-9. PubMed ID: 12515874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetrofosmin imaging in the detection of myocardial viability in patients with previous myocardial infarction: comparison with sestamibi and Tl-201 scintigraphy.
    Acampa W; Cuocolo A; Petretta M; Bruno A; Castellani M; Finzi A; Gerundini P
    J Nucl Cardiol; 2002; 9(1):33-40. PubMed ID: 11845127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.